@imshealth.com
Solutions to help life sciences organizations drive healthcare forward and get the right treatments to patients, faster.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
JPEG
About
Description
IQVIA, headquartered in Durham, North Carolina, is a leading global provider of advanced analytics, technology solutions, and clinical research services to the healthcare industry. With a rich history that spans over 60 years, the company has established itself as a trusted partner to organizations seeking to improve human health outcomes. IQVIA was formed in 2016 through the merger of IMS Health and Quintiles, two prominent players in the healthcare and life sciences industry.
IMS Health, founded in 1954, specialized in healthcare data and analytics, while Quintiles, founded in 1982, focused on contract research and clinical trials. The company offers a diverse range of products and services to its clients, including real-world evidence solutions, clinical trial management systems, regulatory and safety services, patient engagement solutions, and market research and consulting services. By leveraging its extensive data and expertise, IQVIA helps its clients make informed decisions, accelerate the development of drugs and therapies, and ultimately improve patient outcomes.
Operating on a global scale, IQVIA has a presence in more than 100 countries and employs over 67,000 professionals worldwide. The company has established several noteworthy subsidiaries, joint ventures, and partnerships, including its joint venture with Quest Diagnostics called Q2 Solutions, which offers clinical trial laboratory services. In terms of market position, IQVIA stands as a dominant player in the healthcare and life sciences industry.
The company reported over $11 billion in revenue in 2020, solidifying its standing as a global leader. IQVIA faces competition from other major players in the industry, such as Cognizant Technology Solutions, PPD, and Laboratory Corporation of America Holdings. In recent years, IQVIA has continued to evolve its strategy and expand its portfolio of offerings.
One significant event was the acquisition of DrugDev in 2017, bolstering IQVIA's capabilities in clinical trial technology and patient recruitment. Additionally, the company has invested heavily in artificial intelligence and machine learning technologies to enhance its analytics and data solutions. As of the latest available information, IQVIA remains at the forefront of the healthcare industry, leveraging its expertise, innovative solutions, and global presence to drive advancements in healthcare and improve patient outcomes
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories